73PCemiplimab, a human monoclonal anti-PD-1, in patients (pts) with advanced or metastatic hepatocellular carcinoma (HCC): Data from an expansion cohort (EC) in a phase I study. (17th December 2018) - He, A R; Weiss, G J; Falchook, G; Yee, N S; Gil-Martin, M; Shahda, S; Moreno, V; Brana, I; Crittenden, M; Formenti, S; Al-Rajabi, R; Papadopoulos, K P; et al.